603387.SH
基蛋生物
SSE · Healthcare · Medical - Devices · CN
CNY 9.18
−2.55%Year over year
Reported trailing growth
- Revenue
- -1.1%
- EBITDA
- —
- EBIT
- +7.1%
- EPS
- +14.1%
- Free cash flow
- +17.9%
- Operating cash flow
- +2.9%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -16.7%
- EBITDA
- -20.6%
- EBIT
- -25.7%
- Net income
- -23.8%
- EPS
- -23.4%
- Free cash flow
- -3.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026